US OptionsDetailed Quotes
ABUS240517C6000
- 0.02
- 0.000.00%
15min DelayClose Apr 5 12:40 ET
0.00High0.00Low
0.00Open0.02Pre Close0 Volume0 Open Interest6.00Strike Price0.00Turnover4861.33%IV83.54%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.02Time Value100Contract SizeAmericanOptions Type0.0487Delta0.0894Gamma164.00Leverage Ratio-2.4110Theta0.0000Rho7.98Eff Leverage0.0000Vega
Arbutus Biopharma Stock Discussion
Sign in to post a comment
🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US$ Phase 2
$Supernus Pharmaceuticals(SUPN.US$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US$ Phase 2a
$MorphoSys(MOR.US$ Phase 2
$Nuvation Bio(NUVB.US$ Phase 2
$ALX Oncology(ALXO.US$ Phase 2
$BioXcel Therapeutics(BTAI.US$ Phase 2
$Purple Biotech(PPBT.US$ Phase 2
$Arcus Biosciences(RCUS.US$ Phase 2
$Medicenna Therapeutics(MDNAF.US$ Phase 2b
$Affimed NV(AFMD.US$ Phase 2
$Barinthus Biotherapeutics(BRNS.US$ Phase 2b...
$Iovance Biotherapeutics(IOVA.US$ Phase 2
$Supernus Pharmaceuticals(SUPN.US$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US$ Phase 2a
$MorphoSys(MOR.US$ Phase 2
$Nuvation Bio(NUVB.US$ Phase 2
$ALX Oncology(ALXO.US$ Phase 2
$BioXcel Therapeutics(BTAI.US$ Phase 2
$Purple Biotech(PPBT.US$ Phase 2
$Arcus Biosciences(RCUS.US$ Phase 2
$Medicenna Therapeutics(MDNAF.US$ Phase 2b
$Affimed NV(AFMD.US$ Phase 2
$Barinthus Biotherapeutics(BRNS.US$ Phase 2b...
6
1
Arbutus Biopharma's worrying high P/S ratio is underscored by its falling revenue. Investors could pay a steep premium as these declines might significantly affect the stock's value.
Gainers:
In reaction to earnings/guidance:
• $Super Micro Computer(SMCI.US$ +18%, $Nokia Oyj(NOK.US$ +7.7%, $Danaher(DHR.US$ +6.3%, $RLI Corp(RLI.US$ +5%, $CSX Corp(CSX.US$ +4.3%, $Las Vegas Sands(LVS.US$ +4.2%, $Alcoa(AA.US$ +3.4%(also authorizes new $500 mln share repurchase program)
• $Steel Dynamics(STLD.US$ +2.8%, $Herc Holdings(HRI.US$ +2.6%, $Tesla(TSLA.US$ +2.5%, $Philip Morris International(PM.US$ +2.5%, $F.N.B. Corp(FNB.US$ ...
In reaction to earnings/guidance:
• $Super Micro Computer(SMCI.US$ +18%, $Nokia Oyj(NOK.US$ +7.7%, $Danaher(DHR.US$ +6.3%, $RLI Corp(RLI.US$ +5%, $CSX Corp(CSX.US$ +4.3%, $Las Vegas Sands(LVS.US$ +4.2%, $Alcoa(AA.US$ +3.4%(also authorizes new $500 mln share repurchase program)
• $Steel Dynamics(STLD.US$ +2.8%, $Herc Holdings(HRI.US$ +2.6%, $Tesla(TSLA.US$ +2.5%, $Philip Morris International(PM.US$ +2.5%, $F.N.B. Corp(FNB.US$ ...
11
$WiMi Hologram Cloud(WIMI.US$Not leaving. Actually will buy some more!
$Nokia Oyj(NOK.US$ $Arbutus Biopharma(ABUS.US$
$Nokia Oyj(NOK.US$ $Arbutus Biopharma(ABUS.US$
Gainer:
• $Red Robin(RRGB.US$ +13.8% (In reaction to earnings)
• $PMV Pharmaceuticals(PMVP.US$ +11.2% (ASCO-related announcement)
• $Sumo Logic(SUMO.US$ +10.8% (In reaction to earnings)
• $Adicet Bio(ACET.US$ +9.6% (ASCO-related announcement)
• $Dell Technologies(DELL.US$ +9.6% (In reaction to earnings)
• $ImmunoGen(IMGN.US$ +8.7% (ASCO-related announcement)
• $Ulta Beauty(ULTA.US$ +7.9% (In reaction to earnings)
• $Zymergen(ZY.US$ +7.8% (to...
• $Red Robin(RRGB.US$ +13.8% (In reaction to earnings)
• $PMV Pharmaceuticals(PMVP.US$ +11.2% (ASCO-related announcement)
• $Sumo Logic(SUMO.US$ +10.8% (In reaction to earnings)
• $Adicet Bio(ACET.US$ +9.6% (ASCO-related announcement)
• $Dell Technologies(DELL.US$ +9.6% (In reaction to earnings)
• $ImmunoGen(IMGN.US$ +8.7% (ASCO-related announcement)
• $Ulta Beauty(ULTA.US$ +7.9% (In reaction to earnings)
• $Zymergen(ZY.US$ +7.8% (to...
11
The Court of Appeals for the Federal Circuit (CAFC) just issued it's Mandate in connection with $Moderna(MRNA.US$'s unsuccessful appeal of the '069 patent's validity. So the CAFC is now done with the case. Good news for $Arbutus Biopharma(ABUS.US$ .
2
$Moderna(MRNA.US$ 's deadline for filing a petition for rehearing at the Federal Circuit for the '069 patent case (no. 20-2329) passed last night, without any filing by MRNA. This is good for $Arbutus Biopharma(ABUS.US$ and $ROLV
3
2
$Arbutus Biopharma(ABUS.US$ mordena pls pay 💰 for this
1
No comment yet
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long